Company news

Mayne Pharma Group Ltd. news in 2023

Mayne Pharma Group Ltd.'s news releases, calls and decks from 2023, newest first.

View company

Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 29, 2023

Issuance of additional US Patent for NEXTSTELLIS

November 5, 2023

Mayne Pharma provides update on first quarter 2024 trading and outlook

October 19, 2023

Mayne Pharma provides update on 1Q FY24 trading and outlook

October 17, 2023

2023 Full Year Results Investor Presentation

August 30, 2023

2023 Full Year Results Media Release

August 30, 2023

Preliminary Final Report

August 30, 2023

MYX provides investor update & announces on market buyback

May 9, 2023

Mayne Pharma May 2023 market update presentation

May 9, 2023

MYX completes sale of US retail generics business for US$90m

April 10, 2023

Update on sale of US retail generics portfolio

April 2, 2023

Mayne Pharma announces cancellation of capital return

February 27, 2023

2023 Half Year Investor Presentation

February 27, 2023

2022 Half Year Media Release

February 27, 2023

Mayne Pharma announces sale of US retail generics business

February 27, 2023

Mayne Pharma to restate US dermatology net revenue for FY22

February 14, 2023

Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARING

January 16, 2023

Mayne Pharma provides update on capital management timeline

January 11, 2023

MYX completes TherapeuticsMD product licensing transaction

January 2, 2023

Decks in 2023